{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:55:54Z","timestamp":1793476554089,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018286","name":"Dutch Arthritis Society","doi-asserted-by":"publisher","award":["18-1-403"],"award-info":[{"award-number":["18-1-403"]}],"id":[{"id":"10.13039\/100018286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jtauto.2024.100246","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:40:37Z","timestamp":1718869237000},"page":"100246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-6208","authenticated-orcid":false,"given":"Ellen D.","family":"Kaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-5937","authenticated-orcid":false,"given":"Tammo E.","family":"Brunekreef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Drylewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas L.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-4151","authenticated-orcid":false,"given":"Maarten","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Leavis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-5785","authenticated-orcid":false,"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-8982","authenticated-orcid":false,"given":"Michiel","family":"van der Vlist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-2683","authenticated-orcid":false,"given":"Henny G.","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2024.100246_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0000000000000480","article-title":"Epidemiology of systemic lupus erythematosus: an update","volume":"30","author":"Stojan","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41584-018-0133-2","article-title":"New therapeutic strategies in systemic lupus erythematosus management","volume":"15","author":"Gatto","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib3","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1177\/09612033211061475","article-title":"Something new about prognostic factors for lupus nephritis? A systematic review","volume":"30","author":"Rodriguez-Almaraz","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100246_bib4","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.40653","article-title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","volume":"70","author":"Toro-Dominguez","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/ar3101","article-title":"Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus","volume":"12","author":"Kariuki","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2024.100246_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122312","article-title":"Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus","volume":"5","author":"Haynes","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtauto.2024.100246_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275016","article-title":"Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews","volume":"17","author":"Guimaraes","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2024.100246_bib8","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1093\/rheumatology\/keac083","article-title":"Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study","volume":"61","author":"Wahadat","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2024.100246_bib9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative analysis reveals a molecular stratification of systemic autoimmune diseases","volume":"73","author":"Barturen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/ard.2004.024943","article-title":"Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus","volume":"64","author":"Marto","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2024.100246_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","article-title":"Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study","volume":"33","author":"ter Borg","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100246_bib13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2024.100246_bib14","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtauto.2024.100246_bib15","first-page":"E208","article-title":"Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial","volume":"1","author":"Furie E","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2024.100246_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100246_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2024.100246_bib18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/key067","article-title":"Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome","volume":"57","author":"van der Linden","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2024.100246_bib19","article-title":"Interferon alpha enhances B cell activation associated with FOXM1 induction: potential novel therapeutic strategy for targeting the plasmablasts of systemic lupus erythematosus","volume":"11","author":"Akita","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2024.100246_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/icb.2012.10","article-title":"Role of type I interferons in the activation of autoreactive B cells","volume":"90","author":"Kiefer","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jtauto.2024.100246_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210485","article-title":"Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use","volume":"75","author":"van den Hoogen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2024.100246_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000531","article-title":"Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies","volume":"8","author":"Brunekreef","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jtauto.2024.100246_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.130984","article-title":"Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center","volume":"41","author":"Artim-Esen","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0961203316641770","article-title":"Multiparametric detection of autoantibodies in systemic lupus erythematosus","volume":"25","author":"Budde","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100246_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032001","article-title":"Two major autoantibody clusters in systemic lupus erythematosus","volume":"7","author":"Ching","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2024.100246_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jtauto.2024.100246_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","article-title":"Cytokine and autoantibody clusters interaction in systemic lupus erythematosus","volume":"15","author":"Pacheco","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jtauto.2024.100246_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2024.100246_bib29","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.4049\/jimmunol.1601142","article-title":"Blood-borne RNA correlates with disease activity and IFN-stimulated gene expression in systemic lupus erythematosus","volume":"197","author":"Doedens","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2024.100246_bib30","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.21890","article-title":"Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies","volume":"54","author":"Hua","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100246_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2009.04057.x","article-title":"Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes","volume":"159","author":"Li","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2024.100246_bib32","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"Lovgren","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100246_bib33","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1093\/rheumatology\/keaa167","article-title":"Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers","volume":"59","author":"Chasset","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2024.100246_bib34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100246_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100246_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13075-019-1929-4","article-title":"Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles","volume":"21","author":"Reynolds","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2024.100246_bib37","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1177\/0961203314546020","article-title":"Anti-ribosomal P antibodies are associated with elevated circulating IFNalpha and IL-10 levels in systemic lupus erythematosus patients","volume":"23","author":"Mozo","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100246_bib38","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1038\/s41598-020-60563-9","article-title":"Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus","volume":"10","author":"Smith","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2024.100246_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/CS20070339","article-title":"Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis","volume":"114","author":"Sakamoto","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jtauto.2024.100246_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/JLB.2A0320-283RR","article-title":"EPH receptor B2 stimulates human monocyte adhesion and migration independently of its EphrinB ligands","volume":"108","author":"Vreeken","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jtauto.2024.100246_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160283","article-title":"Anti-Ephrin type-B receptor 2 (EphB2) and anti-three prime histone mRNA EXonuclease 1 (THEX1) autoantibodies in scleroderma and lupus","volume":"11","author":"Azzouz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2024.100246_bib42","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3899\/jrheum.161121","article-title":"Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: a longterm prospective study","volume":"44","author":"Tselios","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3899\/jrheum.181232","article-title":"Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis","volume":"47","author":"Bruschi","year":"2020","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100246_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtauto.2024.100246_bib45","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res. Ther."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909024000169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T05:30:51Z","timestamp":1733981451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909024000169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S2589909024000169"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100246","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100246"}}